Systemic bevacizumab for treatment of recurrent respiratory papillomatosis

X Zhao, J Wang, Q Chen, X Wu, W Mao, J Ma… - European Archives of …, 2024 - Springer
Objectives To characterize treatment response of recurrent respiratory papillomatosis (RRP)
including adult-onset RRP (AORRP) and juvenile-onset RRP (JORRP) to systemic …

Factors associated with iatrogenic laryngeal injury in recurrent respiratory papillomatosis

RJ So, AT Hillel, KM Motz, LM Akst… - … –Head and Neck …, 2024 - Wiley Online Library
Objective To describe iatrogenic laryngeal injury and identify its risk factors in recurrent
respiratory papillomatosis (RRP) patients receiving surgical care. Study Design Case …

Healthcare Spending and Systemic Bevacizumab for Recurrent Respiratory Papillomatosis

AD Schuman, AC Chapel, P You, R Venkatramani… - Journal of Voice, 2024 - Elsevier
Objectives Juvenile-onset recurrent respiratory papillomatosis (JoRRP) is a rare, costly
condition linked to human papillomavirus. Standard of care is serial surgical debridement …

Low‐Dose Cisplatin‐Based Radiation Therapy for Refractory Recurrent Respiratory Papillomatosis

E Takatsuki, T Kono, S Tomisato… - The Laryngoscope, 2024 - Wiley Online Library
Recurrent respiratory papilloma (RRP) often presents multiple lesions in the respiratory tract
and sometimes becomes fatal because of severe airway obstruction. We report the case of a …

A case report describing the use of systemic bevacizumab in the treatment of recurrent respiratory papillomatosis with pulmonary involvement

A O'Brien, E Shafuddin - Respirology Case Reports, 2023 - Wiley Online Library
Recurrent respiratory papillomatosis (RRP) is a rare disease characterized by recurrent
papilloma along the aerodigestive tract. In this case, we describe a 16‐year‐old with …

[HTML][HTML] Prophylactic HPV Vaccines

AD Friedman - bulletin.entnet.org
Woman Getting Vaccine Some prophylactic HPV vaccines also include protection against
types 6 and 11, including the current nonavalent vaccine, Gardasil 9®(FDA approved in …